Molecular Docking Study For Adenosine Monophosphate-Activated Protein Kinase Agonist From Syzygium Cumini For Treatment Of Diabetes Mellitus-Type 2. Journal of Pharmaceutical Negative Results [Internet]. 2023 Jan. 1 [cited 2026 Jun. 6];:1078-85. Available from: https://www.pnrjournal.com/index.php/home/article/view/6925